The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A decision-making tool for first-line treatment in advanced non–small-cell lung cancer based on plasma proteome biomarkers.
 
Itamar Sela
Employment - Oncohost
Stock and Other Ownership Interests - Oncohost
Patents, Royalties, Other Intellectual Property - Oncohost
 
Petros Christopoulos
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Novartis; Pfizer; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); Roche (Inst); Takeda (Inst)
 
Igor Puzanov
Stock and Other Ownership Interests - Celldex; Celldex (I)
Consulting or Advisory Role - Amgen; Iovance Biotherapeutics; Merck; Nektar; Nouscom; Oncorus; Roche; Seneca Therapeutics
 
Jair Bar
Stock and Other Ownership Interests - Causalis
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche; Roche/Genentech; Takeda
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Immunai (Inst); MSD (Inst); Novartis (Inst); Oncohost (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Alona Zer
Consulting or Advisory Role - AstraZeneca; MSD; Novartis; Roche; Steba Biotech; Takeda
 
Mor Moskovitz
Consulting or Advisory Role - Abbvie; AstraZeneca; BMSi; Boehringer Ingelheim; MSD; Pomicell; Roche Belgium; Takeda Science Foundation
 
Niels Reinmuth
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dohme; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Janssen
 
Michal Lotem
No Relationships to Disclose
 
Rivka Katzenelson
No Relationships to Disclose
 
Abed Agbarya
Consulting or Advisory Role - AstraZeneca; BMSi; Novartis; Pfizer; Roche; Takeda Science Foundation
Research Funding - BMSi
 
David Farrugia
No Relationships to Disclose
 
Gillian Price
No Relationships to Disclose
 
Helen Cheley
No Relationships to Disclose
 
Mahmud Abu-Amana
No Relationships to Disclose
 
Kimberly McGregor
Employment - Foundation Medicine; OncoCyte
Stock and Other Ownership Interests - OncoCyte; Roche/Genentech
 
Yanyan Lou
Consulting or Advisory Role - AstraZeneca; Janssen; Lilly; Turning Point Therapeutics
Research Funding - Blueprint Medicines (Inst); Daiichi-Sankyo (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst); Tolero Pharmaceuticals (Inst)
 
Raya Leibowitz
Honoraria - BMSi; MSD; Pfizer; Roche Belgium
Consulting or Advisory Role - Pfizer
 
Adam P. Dicker
Stock and Other Ownership Interests - Oncohost
Consulting or Advisory Role - Aptar Pharma; Blue Spark Technologies; CVS; Deallus; EmpiricaLab; Genentech; Hengrui Pharmaceutical; IBA; Janssen; Oncohost; Onconova Therapeutics; Orano Med; SBR Biotechnologies
Patents, Royalties, Other Intellectual Property - We recently filed a patient "DOPED BEO COMPOUNDS FOR OPTICALLY STIMULATED LUMINESCENCE (OSL) AND THERMOLUMINESCENCE (TL) RADIATION DOSIMETRY"
Expert Testimony - Wilson Sonsini
Travel, Accommodations, Expenses - Oncohost
Other Relationship - European Commission
(OPTIONAL) Uncompensated Relationships - Dreamit Ventures; Google
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Bristol-Myers Squibb-Ono Pharmaceutical
Consulting or Advisory Role - Abbvie; Arcus Biosciences; AstraZeneca; Bristol-Myers Squibb; Curio Science; EMD Serono; Genentech/Roche; GlaxoSmithKline; Intellisphere; InThought; Iovance Biotherapeutics; Janssen; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Merck; Merck KGaA; Mirati Therapeutics; MSD Oncology; NCCN/AstraZeneca; Novartis; OncLive/MJH Life Sciences; Pfizer; PPD; Regeneron; Roche; Sanofi
 
David R. Gandara
Honoraria - Amgen; Merck
Consulting or Advisory Role - Adagene (Inst); AstraZeneca (Inst); Daiichi Sankyo Alliance; Guardant Health (Inst); Guardant Health (Inst); IO Biotech (Inst); Lilly; Novartis; Ocean Genomics (Inst); OncoCyte (Inst); OncoHost (Inst); Roche/Genentech (Inst); Sanofi
Research Funding - Amgen (Inst); AstraZeneca (Inst); Genentech (Inst); Merck (Inst)